Technology & Software Global On demand · 24-48h

Global Pulmonary Nodule CT Image Auxiliary Detection Software Market Strategic Research Report

Global Pulmonary Nodule CT Image Auxiliary Detection Softwar…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Pulmonary Nodule CT Image Auxiliary Detection Software Market
$4782025
20.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Cloud Deployment, Local Deployment

By Application: Hospital, Medical Center

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Wanliyun Medical Information Technology (Beijing) Co., Ltd., Hangzhou Shenrui Bolian Technology Co., Ltd., Neusoft Medical Systems Co., Ltd., Shanghai Fosun Pharmaceutical Group (Shanghai Xingmai Information Technology Co., Ltd.), United Imaging Intelligence., Hangzhou Yitu Medical Technology Co., Ltd., Beijing Inference Technology Co., Ltd., Huiying Medical Technology (Beijing) Co., Ltd., Yukun (Beijing) Network Technology Co., Ltd., Suzhou Voxel Information Technology Co., Ltd.

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 88 pages
Market size 2025
$478
Million USD
Forecast CAGR
20.7%
2025-2032
Forecast 2032
$1783.9
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Pulmonary Nodule CT Image Auxiliary Detection Software market size is predicted to grow from US$ 478 million in 2025 to US$ 1,749 million in 2032; it is expected to grow at a CAGR of 20.7% from 2026 to 2032.

Pulmonary nodule CT image aided detection software is based on medical knowledge, combined with computer technology, image processing technology and artificial intelligence. This product belongs to artificial intelligence medical device software, based on the basic framework of deep learning technology, it can realize the automatic detection of pulmonary nodules. On the basis of ensuring that the accuracy of pulmonary nodule detection meets clinical needs, the detection efficiency is improved, the misdiagnosis rate and missed diagnosis rate are reduced, and the workload of doctors is reduced.

Global key Pulmonary Nodule CT Image Auxiliary Detection Software players cover Wanliyun Medical Information Technology (Beijing) Co., Ltd., Hangzhou Shenrui Bolian Technology Co., Ltd., Neusoft Medical Systems Co., Ltd., Shanghai Fosun Pharmaceutical Group (Shanghai Xingmai Information Technology Co., Ltd.), United Imaging Intelligence., etc.

This report presents a comprehensive overview of the global Pulmonary Nodule CT Image Auxiliary Detection Software market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Cloud Deployment
  • Local Deployment

Segment by Application

  • Hospital
  • Medical Center

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pulmonary Nodule CT Image Auxiliary Detection Software market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Medical Center evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Pulmonary Nodule CT Image Auxiliary Detection Software Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 20.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$478
2025
Forecast
$1783.9
2032
CAGR
20.7%
2025–2032
Régions
5
global
Key companies
Wanliyun Medical Information Technology (Beijing) Co., Ltd.Hangzhou Shenrui Bolian Technology Co., Ltd.Neusoft Medical Systems Co., Ltd.Shanghai Fosun Pharmaceutical Group (Shanghai Xingmai Information Technology Co.Ltd.)United Imaging Intelligence.Hangzhou Yitu Medical Technology Co., Ltd.Beijing Inference Technology Co., Ltd.
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Cloud DeploymentLocal Deployment
By Application
HospitalMedical Center

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Cloud Deployment
  • 3.1.3 Local Deployment
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Medical Center
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Wanliyun Medical Information Technology (Beijing) Co., Ltd.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Hangzhou Shenrui Bolian Technology Co., Ltd.
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Neusoft Medical Systems Co., Ltd.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Shanghai Fosun Pharmaceutical Group (Shanghai Xingmai Information Technology Co., Ltd.)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 United Imaging Intelligence.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Hangzhou Yitu Medical Technology Co., Ltd.
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Beijing Inference Technology Co., Ltd.
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Huiying Medical Technology (Beijing) Co., Ltd.
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Yukun (Beijing) Network Technology Co., Ltd.
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Suzhou Voxel Information Technology Co., Ltd.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Pulmonary Nodule CT Image Auxiliary Detection Software market?
The global Pulmonary Nodule CT Image Auxiliary Detection Software market is estimated at US$ 478 million in 2025 (base year) and is projected to reach US$ 1.75 billion by 2032.
What is the forecast CAGR for the Pulmonary Nodule CT Image Auxiliary Detection Software market?
The market is expected to grow at a CAGR of 20.7% from 2026 to 2032, expanding from US$ 478 million in 2025 to US$ 1.75 billion in 2032, roughly 3.7 times its base-year value.
What is Pulmonary Nodule CT Image Auxiliary Detection Software?
Pulmonary nodule CT image aided detection software is based on medical knowledge, combined with computer technology, image processing technology and artificial intelligence. This product belongs to artificial intelligence medical device software, based on the basic framework of deep learning technology, it can realize the automatic detection of pulmonary nodules.
What are the main segments of the Pulmonary Nodule CT Image Auxiliary Detection Software market by type?
By type, the market is segmented into Cloud Deployment and Local Deployment.
Which applications drive demand in the Pulmonary Nodule CT Image Auxiliary Detection Software market?
Key applications covered include Hospital and Medical Center.
Who are the key players in the Pulmonary Nodule CT Image Auxiliary Detection Software market?
Key players profiled include Wanliyun Medical Information Technology (Beijing) Co., Hangzhou Shenrui Bolian Technology Co., Neusoft Medical Systems Co., Shanghai Fosun Pharmaceutical Group (Shanghai Xingmai Information Technology Co., Ltd.), United Imaging Intelligence., Hangzhou Yitu Medical Technology Co., Beijing Inference Technology Co. and Huiying Medical Technology (Beijing) Co., among 10 companies covered in total.
Which regions and countries are covered for Pulmonary Nodule CT Image Auxiliary Detection Software?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Pulmonary Nodule CT Image Auxiliary Detection Software market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital and Medical Center, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Pulmonary Nodule CT Image Auxiliary Detection Software market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.